SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : ajtj's Post-Lobotomy Market Charts and Thoughts

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
skier31
To: skier31 who wrote (95501)10/3/2025 10:41:08 AM
From: Sun Tzu1 Recommendation  Read Replies (1) of 96933
 
There was a trading "buy signal" in late January / early February but it was accompanied with yellow flags.

The stock was still volatile and rising much faster than its trendline and stochastic (top indicator) which was still below the midline. Furthermore the trend (black moving average) was still pointing down. And finally my RSI (2nd indicator) was overbought and due for a pullback.

The combination of all this meant it was more likely to be a bear rally than a genuine trend change. So the cautious (prudent?) thing to do was to either wait for a pullback and reassess or only buy a small position and add only after it shows a profit.

Then you had that big drop in February to the green line and then it built a base and rose from it. At that time it became a solid buy. BUT, by then it was fairly close to the red rail which is your initial sell target / pause point. Was the risk/reward compelling in March? Hard to tell. Biotech companies can gap giant leaps and if you knew and believed in the company, then yes you would take the chance that the red rail won't be a barrier. But as it turned out, it still needed to build a base.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext